12.06.17
908 Devices, a pioneer of analytical devices for chemical and biomolecule analysis, today announced it has been awarded a 10-year fielded contract through the United States Department of Defense’s (DOD) Joint Enterprise-Research, Development, Acquisition, and Production/Procurement (JE-RDAP) omnibus Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle. 908 Devices is recognized for its patented and award-winning high-pressure mass spectrometry™ (HPMS) technology, which powers its line of handheld chemical detection and identification devices. This includes the flagship M908™ and the MX908™, which launched in June of this year.
As a recipient of the $8.2 billion, multi-vendor contract, 908 Devices has been named a qualified contractor by the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD), whose mission it is to protect the Joint Force from weapons of mass destruction by generating affordable capabilities. Leveraging the power of HPMS, 908 Devices will now have the opportunity to compete for JE-RDAP task orders specific to future research, development, production, and fielding of CBRN defense systems.
“We are excited to be named a qualified contractor and for the opportunities it provides.,” said Dr. Kevin J. Knopp, President and CEO, 908 Devices. “We believe our handheld high-pressure mass spec platform can play a critical role in the modern response mission and look forward to working closely with the military to support and enhance its CBRN response needs.”
“This has been an exciting year for our safety and security team, and being a recipient of the JE-RDAP contract allows us to be an innovation partner with the government,” said John Kenneweg, Vice President, 908 Devices. “We will continue to explore and push the boundaries of our HPMS technology so as to be ready to support the evolving CBRN mission for years to come. “